Papaverina Cloridrato Galenica Senese (Papaverine Hydrochloride)

Papaverine hydrochloride, the active ingredient in Papaverina Cloridrato Galenica Senese, is a phosphodiesterase inhibitor presented as a strength/form for oral use. It relaxes smooth muscle and is employed in the management of certain vascular and gastrointestinal conditions.

GNH USA supplies Papaverina Cloridrato Galenica Senese as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Papaverine hydrochloride is used primarily for conditions involving smooth‑muscle spasm within the vascular and gastrointestinal systems. - Coronary artery spasm: Relieves chest‑type pain by dilating coronary vessels. - Peripheral vascular spasm: Improves blood flow in limbs. - Gastrointestinal spasm: Reduces intestinal cramping and facilitates diagnostic procedures.

Papaverine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Flushing: Warm sensation and reddening of the skin. - Headache: Mild to moderate pain, often throbbing. - Nausea: Queasy feeling, sometimes with vomiting. - Dizziness: Light‑headedness or loss of balance. - Hypotension: Lowered blood pressure, especially with rapid IV administration.

Serious or Rare Side Effects: - Myocardial infarction: Heart attack due to coronary vasospasm rebound. - Severe hypotension: Marked drop in blood pressure requiring medical intervention. - Arrhythmias: Abnormal heart rhythms that can be life‑threatening. - Anaphylaxis: Acute allergic reaction with airway compromise. - Hepatotoxicity: Liver enzyme elevations indicating possible liver injury.

When using papaverine, clinicians should consider several safety measures. - Contraindications: Avoid in patients with known hypersensitivity to papaverine. - Cardiovascular monitoring: Observe for signs of hypotension or arrhythmia during IV infusion. - Renal impairment: Adjust dosing or monitor closely in severe kidney dysfunction. - Hepatic dysfunction: Use with caution in patients with liver disease. - Drug interactions: Review concomitant medications for additive vasodilatory effects. - Store at ambient temperature: Keep in original container, protect from moisture and direct sunlight.

Papaverine can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Nitrates: Combined vasodilatory effect may cause severe hypotension. - Beta‑blockers: May blunt compensatory heart rate response to hypotension.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: Additive smooth‑muscle relaxation may enhance hypotensive risk. - Anticholinergic agents: May reduce gastrointestinal motility benefits. - MAO inhibitors: Potential for unpredictable cardiovascular effects.